Greater Gift Establishes Scholarship to Increase Diversity in Research Leadership
Greater Gift has announced a $50,000 scholarship to support a minority graduate student enrolled in Wake Forest University’s newly launched Master’s in Clinical Research Management Program. The scholarship is named in honor of Mary Hofmann Murphy, a Winston-Salem native and clinical research participant. The inaugural scholarship was awarded to Darius Ford of Raleigh, a student enrolled in the first cohort of students in the program.
Greater Gift is a non-profit, founded in 2010, with a mission to increase awareness of clinical research, especially among underrepresented communities. Greater Gift’s goal is to further the engagement of underrepresented groups in clinical research by investing in future leaders in the industry. Executive Director Lilly Skok Bunch stated, “We will only have real equity in clinical research participation when the research industry is reflective of our community. This scholarship is a step in that direction.”
The scholarship was named for Mary Hofmann Murphy, a participant in a cancer research trial conducted at Wake Forest Baptist Health with investigators from Wake Forest School of Medicine and Indiana University. “Mary Hofmann Murphy’s journey at Wake Forest Baptist Health is a story of commitment and a desire to help others, including those she may never know, who will benefit from her role in clinical research,” said Jennifer Byrne, Founder and Chair of the Board of Greater Gift. “Mary’s commitment to overcoming hardship and her wish to impact social justice in our world live in the spirit of this scholarship.”
The Master’s in Clinical Research Management program was created to increase the number of professionals entering into the clinical research industry.
For more information, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
